Interim laboratory biosafety guidelines for handling and processing specimens associated with Middle East Respiratory Syndrome

Details

• Alternative Title:
  Interim laboratory biosafety guidelines for handling and processing specimens associated with MERS-CoV
• Corporate Authors:
  Centers for Disease Control and Prevention (U.S.)
• Description:
  To date, little is known about pathogenic potential and transmission dynamics of Middle East Respiratory Syndrome Coronavirus (MERS-CoV). Until more information becomes available, precautions should be taken in collecting and handling specimens that may contain MERS-CoV.
  
  Timely communication between clinical and laboratory staff is essential to minimize the risk incurred in handling specimens from patients with possible MERS-CoV infection. Such specimens should be labeled accordingly, and the laboratory should be alerted to ensure proper specimen handling. General and specific biosafety guidelines for handling MERS-CoV specimens are provided below.
  
  
• Subjects:
  Containment Of Biohazards/standards Coronavirus Infections/prevention & Control Environment, Controlled Infection Control/standards Infectious Disease Transmission, Patient-to-Professional/prevention & Control Inhalation Exposure/prevention & Control Laboratories/standards Middle East Respiratory Syndrome Coronavirus Occupational Exposure/prevention & Control Pathology, Clinical/standards Protective Clothing Protective Devices Risk Factors Safety Specimen Handling

  More +
• Document Type:
  Pamphlet (or booklet)
• Genre:
  Guideline
• Place as Subject:
  United States
• Pages in Document:
  2 numbered pages
• Collection(s):
  Stephen B. Thacker CDC Library
• Main Document Checksum:
  urn:sha256:51ec9e543a6a1970d0c2a3fa2dcc1a3df7e57f8e43f317230a79a880b6f7db23
• Download URL:
  https://stacks.cdc.gov/view/cdc/25586/cdc_25586_DS1.pdf
• File Type:
  [PDF - 77.49 KB ]